Phase 1 Unit, Rigshospitalet genopslog dette
𝐅𝐚𝐬𝐭 𝐒𝐭𝐚𝐫𝐭-𝐔𝐩 𝐓𝐢𝐦𝐞𝐬 𝐢𝐧 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 – 𝐀 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐀𝐝𝐯𝐚𝐧𝐭𝐚𝐠𝐞 𝐟𝐨𝐫 𝐃𝐞𝐧𝐦𝐚𝐫𝐤 How can we make Denmark an even more attractive location for clinical trials? One key factor is ensuring fast and efficient start-up times—and that requires strong public-private collaboration. At Trial Nation, we are actively discussing this with our member companies, CRO partners and clinics across Denmark, because we know that the ability to initiate trials quickly is crucial—not just for our competitiveness, but also for the patients waiting for innovative treatments. Today, we meet with CRO companies to discuss how we can further optimise processes and enhance Denmark’s competitiveness as a leading destination for clinical research. This is an ongoing conversation, and we welcome insights from all stakeholders. What do you see as the biggest opportunity for further improving trial start-up times? Let’s continue refining and optimising processes to make clinical trials in Denmark even faster, smarter, and more efficient!